Interleukin-1 as a therapeutic target in gout.

Interleukin-1 as a therapeutic target in gout.

Item
http://www.wikidata.org/entity/Q38336631
Gout Classification Criteria: Update and ImplicationsGout increases risk of fracture: A nationwide population-based cohort study.Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout.Updates on the treatment of gout, including a review of updated treatment guidelines and use of small molecule therapies for difficult-to-treat gout and gout flares.Management of Gout and Hyperuricemia in CKD.Interleukin-1 Blockade: An Update on Emerging Indications.Inflammation in gout: mechanisms and therapeutic targets.TNF-α potentiates uric acid-induced interleukin-1β (IL-1β) secretion in human neutrophils.Treatment of gout: where are we now?Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.Transmembrane TNF-α is sufficient for articular inflammation and hypernociception in a mouse model of gout
P2860

Interleukin-1 as a therapeutic target in gout.

Item
http://www.wikidata.org/entity/Q38336631
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Interleukin-1 as a therapeutic target in gout.
@en
type
label
Interleukin-1 as a therapeutic target in gout.
@en
prefLabel
Interleukin-1 as a therapeutic target in gout.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Interleukin-1 as a therapeutic target in gout.
@en
P2093
P304
P31
P356
10.1097/BOR.0000000000000143
P433
P478
P577
P698
P921